TLR8 and autoimmune disease: We used mice that were double-knockouts for TLR7 and TLR8 (TLR7/8 KO) to test the hypothesis that a dual antagonist of these receptors could protect from PD degeneration seen as autoimmunity disease, reducing the production of lymphocytes directed against DA neurons.